| NEUROBIOLOGY OF AGING | 卷:72 |
| Fibronectin induces the perivascular deposition of cerebrospinal fluid-derived amyloid-β in aging and after stroke | |
| Article | |
| Howe, Matthew D.1  Atadja, Louise A.1  Furr, J. Weldon1  Maniskas, Michael E.1  Zhu, Liang1  McCullough, Louise D.1  Urayama, Akihiko1  | |
| [1] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurol, 6431 Fannin St, Houston, TX 77030 USA | |
| 关键词: Cerebral amyloid angiopathy; Stroke; Aging; Extracellular; Matrix; Amyloid-beta; Fibronectin; | |
| DOI : 10.1016/j.neurobiolaging.2018.07.019 | |
| 来源: Elsevier | |
PDF
|
|
【 摘 要 】
Cerebral amyloid angiopathy occurs after stroke, but the mechanism underlying the initial amyloid-beta deposition is not fully understood. This study investigates whether overexpression of fibronectin and its receptor, integrin-alpha 5, induces the perivascular deposition of cerebrospinal fluid-derived amyloid-beta after stroke in young and aged animals. We found that stroke impaired the bulk flow of cerebrospinal fluid into the brain parenchyma and further showed that perivascular amyloid-beta deposition was enhanced in aged animals with stroke, which colocalized with integrin-alpha 5 in the basement membrane. Furthermore, we found that stroke dramatically increased the cortical levels of fibronectin and integrin-alpha 5, with further increases in integrin-alpha 5 in aged animals with stroke, fibronectin bound amyloid-beta in vitro, and fibronectin administration increased amyloid-beta deposition in vivo. Finally, aging and stroke impaired performance on the Barnes maze. These results indicate that fibronectin induces the perivascular deposition of amyloid-beta and that increased integrin-alpha 5 further primes the aged brain for amyloid-beta binding. This provides a novel molecular and physiological mechanism for perivascular amyloid-beta deposition after stroke, particularly in aged individuals. (C) 2018 Elsevier Inc. All rights reserved.
【 授权许可】
Free
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 10_1016_j_neurobiolaging_2018_07_019.pdf | 5185KB |
PDF